Blood oxygen level dependent functional magnetic resonance imaging (fMRI) and the Stroop test were used to assess attentional cortex activation in patients with Alzheimer's disease, subcortical vascular dementia, and normal control subjects. Patients with Alzheimer's disease and subcortical vascular dementia demonstrated similar locations of cortical activation, including the bilateral middle and inferior frontal gyri, anterior cingulate and inferior parietal lobule in response to Stroop colour word stimuli. This activation was distinctly decreased in patients with dementia compared with normal control subjects. Different regions of the brain were activated in patients with Alzheimer's disease and subcortical vascular dementia compared with normal controls. fMRI is a useful tool for the study of dementia in humans and has some potential diagnostic value. Further studies with larger numbers of participants are required.
Introduction
Dementia is a condition that presents with symptoms including loss of memory, impairment of judgement and reasoning, and changes in mood, behaviour and the ability to communicate. 1 Alzheimer's disease -a progressive, degenerative disease of the brain -is the most common form of dementia. 2 Vascular dementia -the second most common form of dementia -is caused by impaired blood supply to the brain. 3 Vascular dementia is divided into different types depending on the nature of the vascular disease, with subcortical vascular dementia being an important subtype. 4 During working memory and visual spatial tasks, patients with Alzheimer's disease have been found to have severe cortical function lesions in the hippocampal and parahippocampal regions and in the medial temporal lobe. 5 -7 In spite of the evidence for attentional and executive process lesions in Alzheimer's disease and subcortical vascular dementia, 8, 9 functional imaging studies have not been undertaken using the Stroop test to investigate cortical C Li, J Zheng, J Wang et al. fMRI in Alzheimer's disease and vascular dementia attentional function.
The aim of the present study was to use blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI) and the Stroop test to assess attentional cortex activation in patients with Alzheimer's disease and subcortical vascular dementia. 10 Healthy volunteers with no known nervous system disease were recruited from the local population of Gaotanyan Street, Chongqing, China, as controls.
Patients and methods

PATIENTS
Prescreening by conducting telephone interviews with caregivers was undertaken to exclude patients with physical limitations, poor cognitive status, concurrent illness, metallic implants or visual impairment. The current or past use of medication to treat Alzheimer's disease or subcortical vascular dementia was not an exclusion criterion.
All subjects provided written informed consent. The study was approved by the Medical Research Ethics Committee of Xinqiao Hospital and Southwest Hospital, Third Military Medical University.
FMRI STUDIES
Prior to MRI scanning, all participants were trained to perform the Stroop test, 11 and were fitted with MRI-compatible lenses to correct any refractive errors. An examiner administered the Mini-Mental State Examination (MMSE) 12 to all subjects before the scanning session.
Stroop test stimuli 13, 14 were projected onto a screen mounted on the patient bed of the MRI scanner and an angled mirror gave full view of the screen. Each stimulus was presented for 1250 ms, with an interstimulus interval of 350 ms. Participants were instructed to name the colour of the ink of an incongruent colour word stimulus; the control was a solid white cross, centred on a black background. Subjects practiced the task aloud for one or two runs before scanning. In order to minimize head movement during the scan, subjects were asked to perform the task silently. 13, 14 Imaging studies were performed using a Siemens Sonata 1.5 T MRI scanner (Siemens, Erlangen, Germany). Twenty T1-weighted axial slices (echo time [TE] 13 ms; volume repetition time [TR] 500 ms; field of view 40 × 40 cm; gap 1 mm; data matrix 256 × 192) were obtained parallel to the anterior commissure and commissural posterior line, identified with the aid of a sagittal localizer anatomical image. 15 Functional image data were acquired with an echo-planar imaging sequence (matrix 64 × 64; field of view 220 × 220 cm; TE 40 ms; TR 3000 s; flip angle 90°). High-resolution structural imaging of the entire brain was performed via 3D gradientecho, T1-weighted sequence with the following parameters: matrix 256 × 256; TI (inversion time) 50.5 ms; TE 56.3 ms; TR 511.7 ms; flip angle 11°.
IMAGE PROCESSING AND ANALYSIS
Analysis of Functional NeuroImages software 16 (Biophysics Research Institute, Medical College of Wisconsin, Milwaukee, WI, USA) was used for image processing and analysis. Initially, echo-planar images were coregistered to the image, which minimized fMRI in Alzheimer's disease and vascular dementia image translation and rotation. Data were motion corrected for three translational directions and three possible rotations. 17 Runs with motion in excess of 1.5 mm displacement and 2° rotation were rejected. Corrected images were spatially filtered using a Gaussian filter, with full width at half maximum of 3 mm. The block design time-series was convolved to account for the target reference. A correlation coefficient was calculated for each voxel, indicating the strength of relationship between the subjects' BOLD signal and the target reference function. An unpaired t-test was used to compare this correlation coefficient with a zero value. A P-value < 0.01 with a cluster filter of nine adjacent pixels was considered significant. Functional and anatomical images for each participant were transformed into the Talairach and Tournoux co-ordinate system. 18 Group composite t-maps associated with task performance were obtained.
Results
The study recruited six patients with Alzheimer's disease (three males and three females, mean age 68 years, range 55 -71 years), six subcortical vascular dementia patients (four males and two females, mean age 66 years, range 56 -69 years), and eight healthy controls (three males and five females, mean age 66 years, range 60 -68 years). There were no significant betweengroup differences with respect to age.
Patients with Alzheimer's disease or subcortical vascular dementia scored mildly to moderately demented on the MMSE test (16.0 -22.4, mean 20.4), whereas there was no evidence of dementia in the normal control participants (28.0 -30.0, mean 28.7). All study participants were right-handed.
The percentage of incorrect responses for patients with subcortical vascular dementia was significantly higher than for patients with Alzheimer's disease (5.56 ± 2.42% versus 4.53 ± 1.98%, respectively, P = 0.02), both of which were significantly greater than the percentage of incorrect responses in control subjects (3.22 ± 1.65%, P < 0.01). Reaction time in the Stroop test for patients with subcortical vascular dementia was significantly longer than for patients with Alzheimer's disease (702.12 ± 133.52 ms versus 623.21 ± 95.66, P = 0.03) and longer compared with control subjects (507.22 ± 88.51 ms, P < 0.01 and P < 0.02, respectively)
Patients with Alzheimer's disease or subcortical vascular dementia produced similar cortical activations in response to Stroop test stimuli. Regions activated included the bilateral middle and inferior frontal gyri, anterior cingulate and inferior parietal lobule. This cortex activation was distinctly decreased compared with activation levels in the normal control group (Fig. 1, Table 1 ).
Discussion
The Stroop test is widely used to probe attentional phenomena in cognitive neuroscience studies, including the selection of processing and inhibition of habitual responses. 19 It has become a classic measure of frontal lobe function since its introduction in 1935. 20 Successful test performance requires the focusing of attention on the taskrelevant process, and inhibiting the taskirrelevant. Several studies have utilized the Stroop test 21 or modified Stroop test 22, 23 to explore executive processes. In the present study, participants were instructed to name the colour of the ink of an incongruent colour word stimulus. Since reading is a more automatic cognitive process than colour naming, participants must resolve cognitive interference and inhibit the incorrect response.
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Past investigations have reported cognitive biases and attentional deficits in Alzheimer's disease. 8 Patients with Alzheimer's disease experience significantly larger Stroop interference effects than comparison subjects, and the severity of dementia significantly influences performance. 9 Using fMRI, the present study demonstrated that activation of the prefrontal cortex and anterior cingulate (regions previously implicated in conflict monitoring and cognitive control) during the Stroop test is decreased in patients with Alzheimer's disease or subcortical vascular dementia compared with normal controls. 13, 14 fMRI is a useful tool for the study of dementia in humans and has potential diagnostic value. 5 Experimental evidence from monkeys and humans has shown the prefrontal cortex and anterior cingulate to be important, not only for memory buffering to permit on-line processing, but also for prepotent response inhibition. 24, 25 Lesions in these regions could result in impaired performance in the Stroop test. 26 Human diseases such as schizophrenia involve prefrontal and anterior cingulate abnormalities, and often result in impairment of attentional conflict paradigms. 27 -29 This is the first fMRI study of the attentional cortex to be undertaken in patients with Alzheimer's disease or vascular dementia. As such, the results are preliminary and warrant further investigation. Future investigations should address the limitations of this study by using larger, more diverse patient groups, and correlating online Stroop test performance with measures of brain activity. In addition, it would be of interest to assess other vascular dementia subtypes.
